CATALYST PHARMACEUTICALS INC. - COMMON STOCK
21.48
22-November-24 15:44:58
15 minutes delayed
Stocks
+0.36
+1.70%
Today's range
21.05 - 21.55
ISIN
N/A
Source
NASDAQ
-
Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference
05 Mar 2024 07:03:00 By Nasdaq GlobeNewswire
-
28 Feb 2024 17:03:23 By Nasdaq GlobeNewswire
-
21 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
14 Feb 2024 07:03:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals, Inc. Announces Closing of Public Offering
09 Jan 2024 15:05:13 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
05 Jan 2024 07:02:06 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
04 Jan 2024 15:49:58 By Nasdaq GlobeNewswire
-
18 Dec 2023 05:30:03 By Nasdaq GlobeNewswire
-
05 Dec 2023 07:03:00 By Nasdaq GlobeNewswire
-
04 Dec 2023 07:03:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals To Participate in Piper Sandler 35th Annual Healthcare Conference
16 Nov 2023 07:05:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update
08 Nov 2023 15:11:02 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Receives Two New U.S. Patent Allowances For FIRDAPSE®
02 Nov 2023 09:37:31 By Nasdaq GlobeNewswire
-
30 Oct 2023 07:03:00 By Nasdaq GlobeNewswire
-
26 Oct 2023 14:19:11 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 8, 2023
23 Oct 2023 07:03:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
19 Oct 2023 07:03:00 By Nasdaq GlobeNewswire
-
16 Oct 2023 07:03:00 By Nasdaq GlobeNewswire
-
13 Oct 2023 07:03:00 By Nasdaq GlobeNewswire